German genetic medicine company ViGeneron has announced a rebrand to become VeonGen Therapeutics. The privately-held firm has ...

San Jose, USA-based biotech Allay Therapeutics today announced the completion of a $57.5 million Series D financing round ...

US rare disease meds developer Sarepta Therapeutics (Nasdaq: SRPT) revealed that its rAAVrh74 viral vector used in the ...

US biopharma Cullinan Therapeutics has entered into an agreement with Genrix Bio for an all-indication, exclusive license to ...

The atopic dermatitis market across the seven major markets is forecast to nearly triple in value over the next decade, ...

AI-enabled biotech Juvenescence today announced the acquisition of Ro5 Inc, a proprietary AI drug discovery company. This ...

China’s National Medical Products Administration approved its first domestically-developed nine-valent human papillomavirus ...

Germany’s Formycon has announced that the Brazilian regulatory authority Anvisa has granted marketing authorization for ...

A sweeping legislative package backed by US President Donald Trump could strip health insurance from more than 16 million ...

USA-based subsidiary Vividion Therapeutics has taken over full development and commercialization rights for VVD-214, a ...

The NHS Business Services Authority (NHSBSA) has published the annual Prescription Cost Analysis (PCA) for 2024/25.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to women taking popular medicines ...